Cookies

Our site uses cookies to optimize the content and improve the performance. If you continue the browsing it will be considered that you accept that our webpage may be able to use your cookie files. For more information, please visit the "Privacy Policy" Privacy statement

Customize

Analytics Collect statistics data
Goal _ga, _gat, _gid, _gali
Bismuth(III) subsalicylate
SDSDownload

Bismuth(III) subsalicylate / 500 G

Purity: 99.9% trace metals basis
Synonym: C7H6BiO4; Vismut; Stabisol; Trigastronol; Wismutsubsalicylat; Bismuth oxysalicylate; Bismuth oxysalicylate; Bismuth subsalicylate; Bismuth oxide salicylate; 2-Hydroxy-benzo[1,3,2]dioxabismin-4-one; 2-hydroxy-2H,4H-benzo[d]1,3-dioxa-2-bismacyclohexan-4-one
Molecular Formula: HOC6H4COOBiO
Molecular Weight: 362.09
SKU: MND-55635
CAS Number: 14882-18-9
MDL number: MFCD00085368
EC Number: 238-953-1
Note: Prices are for comparison only. Contact Sales for current pricing.
Packing size: 500 G  
84.70 EUR

Properties

Flash Point (C)Not available
Flash Point (F)Not available
Melting Point>350 °C (lit.)

 Product Description

Bismuth subsalicylate is an over-the-counter medication commonly used to treat diarrhea, indigestion, and heartburn. It works by reducing the secretion of fluids and inflammation in the digestive system.

 

Application:

Bismuth subsalicylate is applied orally to alleviate symptoms associated with gastrointestinal issues such as diarrhea, upset stomach, and nausea. It helps to relieve discomfort by soothing the lining of the digestive tract and reducing diarrhea frequency.

 

 

Articles:

- Metabolism of Bismuth Subsalicylate and Intracellular Accumulation of Bismuth by Fusarium sp. Strain BI

Publication Date: 1 February 2005

Anthony G. Dodge, Lawrence P. Wackett

https://doi.org/10.1128/AEM.71.2.876-882.2005

 

- A Controlled Trial of Bismuth Subsalicylate in Infants with Acute Watery Diarrheal Disease

Publication Date: June 10, 1993

Dante Figueroa-Quintanilla, Eduardo Salazar-Lindo, R. Bradley Sack, Raul Leon-Barua, Silvana Sarabia-Arce, Miguel Campos-Sanchez, and Eduardo Eyzaguirre-Maccan

https://doi.org/10.1056/NEJM199306103282301

 

- Effect of Bismuth Subsalicylate on Gastrointestinal Tolerability in Healthy Volunteers Receiving Oral Delayed-release Dimethyl Fumarate: PREVENT, a Randomized, Multicenter, Double-blind, Placebo-controlled Study

Publication Date: Available online 15 November 2018

Irene Koulinska, Katherine Riester, Spyros Chalkias, Michael R. Edwards

https://doi.org/10.1016/j.clinthera.2018.10.013